Assessment of the Safety and Efficacy of Weighted Wearable Blankets in Healthy Infants During Sleep
Launched by INDIANA UNIVERSITY · May 15, 2024
Trial Information
Current as of February 19, 2025
Terminated
Keywords
ClinConnect Summary
To date, there is no evaluation of the safety or efficacy of weighted wearable blankets on healthy infants during overnight use in the peer-reviewed scientific literature. These are the conditions in which these products are used by consumers, with infants sleeping unobserved throughout the night. Given the rising popularity in the use of weighted wearable blankets in infants and the risk speculated, a study of the potential impact of weighted wearable blankets on infant vital signs is warranted.
Study Design: Direct observational pilot study of the safety of weighted wearable blankets on ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Ability of parent, caregiver or legal guardian/representative to understand a written informed consent document and choose to participate in the study
- • 0-12 months of age
- • Weight greater than or equal to 8 pounds
- • Gestational age 37 weeks or greater
- • Health status: healthy infant without underlying cardiac, neurological, or pulmonary disorders
- • Infant is naive to a weighted wearable blanket
- Exclusion Criteria:
- • Health status: medical diagnosis associated with underlying cardiac, neurological, or pulmonary disorder
- • Weight \< 8 pounds
- • Gestational age \< 37 weeks
- • Gestational use of marijuana, alcohol, or illicit drugs
- • Home environment: use of cigarettes, vaping, e-cigarettes, or marijuana
- • Infant is not naive to a weighted wearable blanket
Trial Officials
Harish Rao, MD
Principal Investigator
Riley Hospital for Children at Indiana University Health
About Indiana University
Indiana University, a leading research institution, is committed to advancing healthcare through innovative clinical trials and rigorous scientific inquiry. With a focus on improving patient outcomes, the university conducts a wide range of studies across various medical disciplines, leveraging its extensive resources and collaborative networks. Indiana University's dedication to ethical research practices and community engagement ensures that its clinical trials not only contribute to scientific knowledge but also prioritize participant safety and well-being. Through its commitment to excellence, Indiana University plays a pivotal role in shaping the future of medicine and enhancing public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Indianapolis, Indiana, United States
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0